bulbar in a sentence

1. — Bulbar polio 2% of paralytic cases

2. Nutrition: Bulbar dysfunction is universal in SMA1 patients.

3. Bulbar ALS refers to the starting point for the neurons affected.

4. The bulbar Memokath™ comes in one version only and expands in one end.

5. people with the bulbar form of dysarthria are characterized by weak facial activities.

6. Manifested in the form of bulbar syndrome (paralysis), in which 3 pairs of cranial nerves are affected.

7. Typical symptoms begin in one of three areas: the arms and legs, the mouth (bulbar), or the respiratory system.

8. The baby usually dies within the first one or two years of life, most commonly due to infection and/or bulbar palsy.

9. bulbar dysarthria of speech is manifested by atrophy or paralysis of the muscles of the pharynx and tongue, decrease in muscle tone.

10. bulbar dysarthria of speech is manifested by atrophy or paralysis of the muscles of the pharynx and tongue, decrease in muscle tone.

11. Approximately 19% of all paralytic polio cases have both bulbar and spinal symptoms; this subtype is called respiratory or bulbospinal polio.

12. Practically in 100% of cases of bulbar syndrome, manifested by the defeat of the wandering, glossopharyngeal nerves, development of glossalgia is observed.

13. in paresis and bulbar palsy, the drug is administered twice a day intramuscularly or subcutaneously for 10-15 days, with a dosage ranging from 5 to 15 mg.

14. paralytic polio has several types, based on the part of your body that's affected- your spinal cord(spinal polio), your brainstem(bulbar polio) or both(bulbospinal polio).

15. paralytic polio has several types, based on the part of your body that's affected- your spinal cord(spinal polio), your brainstem(bulbar polio) or both(bulbospinal polio).

16. the salk vaccine had been 60-70% effective against pv1(poliovirus type 1), over 90% effective against pv2 and pv3, and 94% effective against the development of bulbar polio.

17. The bulbar dysfunction eventually becomes a serious problem for spinal muscular atrophy II patients and only very late in the course of disease for spinal muscular atrophy III patients.